Insider trades
Reshma Rangwala, Chief Officer of Karyopharm Therapeutics KPTI, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $55.6K. The latest trade was on 05/14.
Reshma Rangwala
EVP & Chief Medical Officer
- Company
- Karyopharm Therapeutics KPTI
- First filing
- 23/03/02
- Trades
- 21 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- −$55.6K
- Last trade
- 05/14
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 05/14 | 05/15 | 408 sh | $9.50 | $3,876 | −0.7% | |
| Open-market sale | 04/21 | 04/22 | 449 sh | $8.94 | $4,014.06 | −0.8% | |
| Open-market sale | 03/02 | 03/03 | 5,066 sh | $9.41 | $47,671.06 | −8.2% | |
| Open-market sale | 25/09/15 | 25/09/16 | 408 sh | $6.43 | $2,623.44 | −1.4% | |
| Open-market sale | 25/04/23 | 25/04/24 | 419 sh | $6.17 | $2,585.23 | −1.4% | |
| Open-market sale | 25/03/04 | 25/03/06 | 3,587 sh | $6.29 | $22,562.23 | −10.9% | |
| Open-market sale | 24/04/22 | 24/04/23 | 6,789 sh | $1.17 | $7,943.13 | −1.9% | |
KPTI | Open-market sale | 24/02/29–24/03/01 | 24/03/04 | 21,636 sh2 trades | $1.18avg. | $25,493.19 | −5.8% |
KPTI | Open-market sale10b5-1 plan | 23/04/20 | 23/04/24 | 6,770 sh2 trades | $4.05avg. | $27,416.2 | −4.1% |